By Anya Wassenberg on June 2, 2022
Sensors, music, and software – together, they can be used in therapies designed to improve the ability to walk in patients with impaired nervous systems.
Two American companies, MedRhythms and Biogen, have signed an agreement to take that knowledge and create MR-004, a digital therapy that will be available by prescription specifically to treat MS patients who are experiencing difficulties with walking. It will be the first treatment of its kind if approved.
Biogen is a multinational specializing in developing and delivering treatments for neurological conditions. MedRhythms, the company, grew out of a therapy practice at Spaulding Rehabilitation Hospital in Boston.
